Literature DB >> 21647533

Can recombinant thrombomodulin play a preventive role for veno-occlusive disease after haematopoietic stem cell transplantation?

S Nomura, R Ozasa, T Nakanishi, S Fujita, M Miyaji, S Mori, T Yokoi, T Ito, K Ishii.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21647533     DOI： 10.1160/TH10-12-0802

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  7 in total

1.  Improvement of high serum levels of biomarkers of endothelial injury after allogeneic hematopoietic SCT with pre-existing severe hepatitis using recombinant human soluble thrombomodulin.

Authors:  T Saito; Y Inoue; K Sato; Y Tsuruoka; R Shigefuku; H Ikeda; C Okuse; M Takahashi; I Miura
Journal:  Bone Marrow Transplant       Date:  2014-07-28       Impact factor: 5.483

2.  Sinusoidal obstructive syndrome prophylaxis with recombinant human soluble thrombomodulin is feasible in gemtuzumab ozogamicin-treated patients undergoing allogeneic hematopoietic cell transplantation.

Authors:  S Yamamoto; R Matsuno; Y Sugishita; R Kaneko; N Okamoto; M Koganesawa; S Fujita; K Akiyama; D Toyama; K Isoyama
Journal:  Bone Marrow Transplant       Date:  2017-04-03       Impact factor: 5.483

3.  A critical role of the Gas6-Mer axis in endothelial dysfunction contributing to TA-TMA associated with GVHD.

Authors:  Miki Furukawa; Xintao Wang; Hiroshi Ohkawara; Masahiko Fukatsu; Lobna Alkebsi; Hiroshi Takahashi; Kayo Harada-Shirado; Akiko Shichishima-Nakamura; Satoshi Kimura; Kazuei Ogawa; Takayuki Ikezoe
Journal:  Blood Adv       Date:  2019-07-23

4.  Potentially life-threatening coagulopathy associated with simultaneous reduction in coagulation and fibrinolytic function in pediatric acute leukemia after hematopoietic stem-cell transplantation.

Authors:  Takashi Ishihara; Keiji Nogami; Tomoko Matsumoto; Akitaka Nomura; Yasufumi Takeshita; Satoshi Ochi; Midori Shima
Journal:  Int J Hematol       Date:  2017-03-16       Impact factor: 2.490

5.  Thrombomodulin alleviates murine GVHD in association with an increase in the proportion of regulatory T cells in the spleen.

Authors:  T Ikezoe; J Yang; C Nishioka; A Yokoyama
Journal:  Bone Marrow Transplant       Date:  2014-09-22       Impact factor: 5.483

6.  A donor thrombomodulin gene variation predicts graft-versus-host disease development and mortality after bone marrow transplantation.

Authors:  Haruka Nomoto; Akiyoshi Takami; J Luis Espinoza; Keitaro Matsuo; Shohei Mizuno; Makoto Onizuka; Koichi Kashiwase; Yasuo Morishima; Takahiro Fukuda; Yoshihisa Kodera; Noriko Doki; Koichi Miyamura; Takehiko Mori; Shinji Nakao; Shigeki Ohtake; Eriko Morishita
Journal:  Int J Hematol       Date:  2015-08-06       Impact factor: 2.490

7.  Successful Control of Disseminated Intravascular Coagulation by Recombinant Thrombomodulin during Arsenic Trioxide Treatment in Relapsed Patient with Acute Promyelocytic Leukemia.

Authors:  Motohiro Shindo; Katsuya Ikuta; Lynda Addo; Satoshi Ito; Mikihiro Fujiya; Yoshihiro Torimoto; Yutaka Kohgo
Journal:  Case Rep Hematol       Date:  2012-09-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.